BrainCells, Lundbeck, Emiliem, Invitrogen, MDS, Harvard Bio, Nanoentek, ABI

Mar 30, 2007

Premium

BrainCells, Lundbeck Collaborate On CNS Drug Research

BrainCells announced this week the formation of a research collaboration with H. Lundbeck A/S.

The financial details of the collaboration were not disclosed.

In the collaboration, BCI will use its proprietary neurogenesis-based technology to screen central nervous system targets and compounds. The company will determine which targets or compounds promote neurogenesis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Main menu